Abstract: The role of the endogenous anti-inflammatory mediator annexin 1 (AnxA1) in controlling polymorphonuclear leukocyte (PMN) trafficking and activation was addressed using the recently generated AnxA1 null mouse. In the zymosan peritonitis model, AnxA1 null mice displayed a higher degree (50 -70%) of PMN recruitment compared with wild-type littermate mice, and this was associated with reduced numbers of F4/80 ؉ cells. Intravital microscopy analysis of the cremaster microcirculation inflamed by zymosan (6 h time-point) indicated a greater extent of leukocyte emigration, but not rolling or adhesion, in AnxA1 null mice. Real-time analysis of the cremaster microcirculation did not show spontaneous activation in the absence of AnxA1; however, superfusion with a direct-acting PMN activator (1 nM platelet-activating factor) revealed a subtle yet significant increase in leukocyte emigration, but not rolling or adhesion, in this genotype. Changes in the microcirculation were not secondary to alterations in hemodynamic parameters. The phenotype of the AnxA1 null PMN was investigated in two in vitro assays of cell activation (CD11b membrane expression and chemotaxis): the data obtained indicated a higher degree of cellular responses irrespective of the stimulus used. In conclusion, we have used a combination of inflammatory protocols and in vitro assays to address the specific counter-regulatory role of endogenous AnxA1, demonstrating its inhibitory control on PMN activation and the consequent impact on the inflamed microcirculation. J. Leukoc. Biol. 78: 639 -646; 2005.
INTRODUCTION
It is now clear that proinflammatory and anti-inflammatory pathways act in concert to initiate, maintain, and finally resolve the inflammatory reaction [1] . Endogenous mediator systems operate at several stages of the inflammatory response such that blockade of their actions or ablation of their presence by means of gene deletion can exacerbate the response or increase its duration.
Within the complex processes that comprise the innate immune response, migration of white blood cells (WBC) from the vascular lumen into the interstitial tissue is probably the most important and potentially damaging event shared by numerous inflammatory conditions [2] . For this reason, it is not surprising that leukocyte migration is closely controlled. Endogenous inhibitors of leukocyte recruitment include endothelial-derived nitric oxide, adenosine, short-lived lipids produced via transcellular synthesis [3, 4] , and the 37-kDa protein, annexin 1 (AnxA1). Originally termed lipocortin 1 and proposed to be involved in the anti-inflammatory actions of glucocorticoids [5] , AnxA1 was cloned in 1986 and found to be a member of a large family of structurally related proteins [6] . Human and rodent granulocytes [predominantly neutrophils, polymorphonuclear leukocyte (PMN)] contain high levels of this protein [7] [8] [9] , which is rapidly mobilized upon leukocyte adhesion to endothelial monolayers in vitro [10] . In pharmacological studies, exogenous application of human recombinant AnxA1 and its peptido-mimetics exerts inhibitory actions on human PMN activation [11, 12] as well as on PMN recruitment in models of acute inflammation [13, 14] . The latter effect has been described in several experimental settings and in response to various inflammatory stimuli, including zymosan, cytokines, and reperfusion injury [15] [16] [17] .
Much less is known about the role of the endogenous protein. AnxA1 null mice exhibit a prolonged and exacerbated inflammatory response to locally applied stimuli (e.g., paw edema model) [18] and are partially resistant to the antiinflammatory properties of glucocorticoids [18, 19] . More recently, we demonstrated higher susceptibility of AnxA1 null mice to the systemic response promoted by lipopolysaccharide [20] ; in the same study, we reported rapid kinetics of AnxA1 gene activation in the mesenteric microcirculation, suggesting a function for endogenous AnxA1 on microscopic events occurring within inflamed vascular beds.
Similarly, few studies have investigated cell behavior in the absence of AnxA1. Peritoneal macrophages have defected phagocytosis (related to the size of the particle added) and display altered activation profiles if taken from AnxA1 null mice [21] . Similarly, AnxA1 null fibroblasts are more prone to activation, releasing increased amounts of prostaglandins upon stimulation and showing partial resistance to the inhibitory effects of glucocorticoids [22] . In the present study, we have used AnxA1 null mice to increase our knowledge of the role of this mediator in cell activation, by combining analyses of PMN trafficking and interaction with the postcapillary venule endothelium, and selected in vitro assays of activation using bloodpurified PMN.
MATERIALS AND METHODS

Animals
Male wild-type littermate control and AnxA1 null mice (20 -25 g body weight) [18] were maintained on a standard chow pellet diet with tap water ad libitum and were used for all experiments. C57BL/6 male mice (ϳ25 g body weight) were purchased from B&K (Hull, UK). In all cases, animals were housed at a density of five animals per cage in a room with controlled lighting (lights on from 8:00 a.m. to 8:00 p.m.), in which the temperature was maintained at 21-23°C. Animal work was performed according to UK Home Office regulations (Guidance on the Operation of Animals, Scientific Procedures, Act 1986) and complying with the directives of the European Union.
In vivo protocols
Model of peritonitis
Zymosan peritonitis was induced by injecting 1 mg zymosan A (Sigma-Aldrich, Poole, UK) in 0.5 ml phosphate-buffered saline (PBS) [23] . Peritoneal lavage fluid aliquots were stained in Turk's solution and used for total cell counts as well as differential counting (light microscopy values) using an Olympus B061 microscope (London, UK). Remaining lavage fluids were centrifuged at 400 g for 10 min. Pellets were resuspended in fluorescein-activated cell sorter (FACS) wash [PBS containing 0.2% bovine serum albumin (BSA) and 0.1% sodium azide]. Aliquots (10 l 4ϫ10 7 cells/ml concentration) were seeded onto a 96-well plate, and a 1:1 mixture of blocking immunoglobulin G (IgG; human ␥ globulin, 6 mg/ml, in FACS wash) and anti-CD11b antibody (clone 5C6 [24] , a generous gift of Dr. Neil Gozzard, Celltech R&D, Slough, UK) or corresponding isotype control (final concentrations 5 g/ml) was placed on the cells. After 30 min incubation on ice, the plate was washed, and a second incubation was carried out, consisting of a 1:1:1 mixture of Gr1-fluorescein isothiocyanate (FITC; BD Biosciences, Oxfordshire, UK), F4/80-phycoerythrin (Serotec, Oxfordshire, UK), and Streptavidin Tricolor (Caltag Laboratories, Northamptonshire, UK; final concentrations of 1.67 g/ml, 1.00 g/ml, and 0.33 g/ml, respectively) for further 30 min. After washing, cells were fixed with ice-cold cell fixative (CellFix™, BD Biosciences) and analyzed using the CellQuest™ software on a Power Macintosh G3 computer. For each sample, a minimum of 10,000 events was acquired. Gates were constructed around two populations, the FL-1-positive events (Gr1 ϩ ) and FL-2-positive events (F4/ 80 ϩ ). The percentage of total events in each population, together with the level of CD11b expression, was measured.
Intravital microscopy of the mouse cremaster muscle
The mouse cremaster muscle microcirculation was prepared for intravital microscopy as described previously [25] . Briefly, following anesthesia with a mixture of xylazine (7.5 mg/kg) and ketamine (150 mg/kg), the left jugular vein was cannulated with polyethylene tubing (PE10) for drug administration. The cremaster was dissected free of skin and fascia, opened longitudinally, and then pinned out flat against the viewing platform of a plexiglass stage. The preparation was mounted on a Zeiss Axioskop "FS" microscope (original magnification: 40ϫ; Carl Zeiss, Welwyn Garden City, UK) and transilluminated with a 12-V, 100-W halogen light source to observe the microcirculation.
Superfusion of the cremaster muscle with bicarbonate-buffered solution (BBS; g/liter: 7.71 NaCl, 0.25 KCl, 0.14 MgSO 4 , 1.51 NaHCO 3 , and 0.22 CaCl 2 , pH 7.4, at 37°C, gassed with 5% CO 2 /95% N 2 ) at a rate of 2 ml/min began immediately. A Hitachi charged-coupled device color camera (KPC571; Tokyo, Japan) acquired images displayed on a Sony Trinitron color video monitor (PVM 1440QM; Tokyo, Japan) and recorded on a Sony super-VHS videocassette recorder (SVO-9500 MDP) for subsequent off-line analysis. A video time-date generator (FOR.A video timer, VTG-33, Tokyo, Japan) projected the time, date, and stopwatch function onto the monitor.
Platelet-activating factor (PAF)-induced inflammation
After a 30-min stabilization period of BBS superfusion, a postcapillary venule (diameter between 20 and 40 m; length Ͼ100 m) was selected and superfused with 1 nM PAF (C16 form: C 26 H 54 NO 7 P; Sigma-Aldrich) to inflame the tissue. Recordings were then made every 15 min up to a total of 90 min. Off-line analyses were performed to calculate WBC velocity (V) in m/s, the time taken for a leukocyte to roll along 100 m of a vessel wall; extent of leukocyte adhesion, i.e., number of adherent leukocytes (stationary for at least 30 s) in the 100-m vessel length over a 5-min recording; and extent of leukocyte emigration, measured as the number of leukocytes that had emigrated up to 50 m either side of the vessel. Wall shear rate (WSR) was calculated by the Newtonian definition: WSR ϭ 8000 ϫ (V mean /diameter) and expressed in s -1 . Centerline red blood cell (RBC) velocity was also measured on-line using an optical Doppler velocimeter.
The mouse cremaster was also inflamed with zymosan particles as described recently [26] . Briefly, fluorescent zymosan (Alexa Fluor 488-labeled, Molecular Probes, Eugene, OR) was injected into the scrotum at a dose of 30 g in 400 l saline at time 0, and the microcirculation was analyzed at the 6-h time-point. One to three randomly selected, postcapillary venules were observed for each mouse. Leukocyte rolling and adhesion were analyzed as above, whereas leukocyte emigration was determined per field of view (one to three fields per vessel) [26] .
Zymosan phagocytosis
Use of fluorescent zymosan also allowed the quantification of phagocytosis in vivo [26] . For PMN phagocytosis, the cremaster preparation was handled as described above, and at the end of experimentation, fluorescent particles were visualized using a silicon-intensified, low-level light camera (Hamamatsu Photonics, Enfield, UK). Phagocytosis was quantified as the number of transmigrated leukocytes containing fluorescent particles per field of view (more than nine fields of view per mouse were analyzed). The phagocytic response was normalized for the total number of infiltrating leukocytes, and data are presented as index of phagocytosis: (phagocytosing PMN/total PMN) ϫ 100.
In vitro protocols
PMN CD11b expression
Blood was collected by cardiac puncture under halothane (3%) anesthesia from four to six mice from each genotype. Aliquots (1 ml) were then incubated with or without PAF (0.3-3 M), phorbol myristoyl acetate (PMA; 1-10 M), or formyl-Met-Leu-Phe (fMLP; 1-30 M) for 15 min at 37°C. Cells were then washed with 5 ml PBS supplemented with NaN 3 (3% w:v). Smaller aliquots of blood (200 l) were then labeled with 50 l rat anti-mouse CD11b (5 g/ml; clone 5C6) for 60 min at 4°C, using a protocol described previously [17] . After two washes, cells were then stained with 50 l FITC-conjugated rabbit anti-rat IgG antibody (1:50; Serotec) for 5 min at room temperature. Following two further washes in PBS, RBC lysis was performed with Immuno-Lyse™ (Coulter, Luton, UK). Flow cytometry was performed using a FACScan analyzer (Becton Dickinson, Cowley, UK) with an air-cooled 100 mW argon laser, tuned to 488 nm, connected to an Apple Macintosh G3 computer running Cell Quest II software. Forward-and side-scatter characteristics were used to distinguish amongst the three distinct cell populations (lymphocytes, monocytes, and granulocytes) and CD11b levels measured in the FL-1 channel (wavelength of 548 nm), expressing data as units of median fluorescence intensity (MFI) [17] .
Chemotaxis
Blood-isolated mouse neutrophils were produced by negative immunomagnetic separation as described in ref. [27] , using a chilled separation column connected to a VarioMACS™ magnet (Miltenyi Biotec, Bisley, UK). Briefly, mouse blood was incubated with a cocktail of rat anti-mouse monoclonal antibodies:
anti-CD2, anti-CD5, and anti-CD45R (5 g/ml; BD Biosciences), anti-F4/80 (1 g/ml, Serotec), and anti-CD54 (3 g/ml, generous gift from Dr. Chapman, Celltech R&D) for 30 min at 4°C and then washed and incubated with anti-rat IgG MicroBeads (20 l per 10 7 cells) for a further 15 min prior to running the leukocyte/MicroBead mixture through the column and collection of neutrophilrich effluent. The neutrophil-rich population (Ͼ95% PMN) was then resuspended (4ϫ10 6 cells/ml in RPMI 1640, supplemented with 0.1% BSA), and 25 l was loaded on the top well of a NeuroProbe ChemoTx-101-3™ 96-well plate equipped with a 3-m pore-size filter (NeuroProbe, Gaithersburg, MD). As chemoattractants, 0.1-1 nM fMLP or PAF was added in the bottom well in a volume of 27 l and incubated for 2 h at 37°C in 5% CO 2 /95% O 2 atmosphere. The ChemoTx-3™ plate was then centrifuged (312 g, 5 min) to pellet cells migrated on the undersides of the filter. Migrated neutrophils were counted after a 1:1 dilution in Turk's solution, using a Neubauer haematocymometer.
Statistical analysis
All values are expressed as mean Ϯ SE of mean, with number (n) of animals per group where stated. Statistical analysis for the intravital microscopy studies was assessed by Student's t-test (two groups) or by one-way ANOVA followed by Bonferroni post-hoc test (more than two groups). Differences among groups for the in vitro experiments were determined by the Mann-Whitney U test. In all cases, a probability value of P Ͻ 0.05 was considered significant.
RESULTS
Model of peritonitis
Injection of zymosan into the mouse peritoneal cavity of wildtype mice produced a rapid influx of PMN, with a peak at 4 h, which then resolved up to 48 h postinjection (Fig. 1a) . In AnxA1 null mice, this response was more marked with an almost 80% increase in PMN numbers at 4 h. This aspect was confirmed when PMN influx was measured as Gr1 ϩ cells by flow cytometry, as shown in Figure 1b . This rapid response was also characterized by an augmented disappearance of the macrophage population (F4/80 ϩ cells in Fig. 1b) . Absolute macrophage values in the peritoneal cavity were (10 6 per mouse), 2.2 Ϯ 0.4 and 0.8 Ϯ 0.3 for wild-type and AnxA1 null mice, respectively (six mice per group; PϽ0.05). All differences were no longer evident at the 24-h time-point (Fig. 1) 
Mouse cremaster microcirculation activated by zymosan
Having demonstrated a higher degree of PMN influx in AnxA1 null mice injected with zymosan, we then tested whether the same observation was made in another vascular district. To do so, we used a model of zymosan-induced activation of the cremaster microcirculation analyzed at the 6-h time-point [26] .
No differences in the extent of zymosan-induced WBC rolling velocity or adhesion to cremaster postcapillary venules were observed between the two genotypes (Fig. 2, a and b) , However, AnxA1 null mice displayed a greater degree of cell emigration compared with wild-type control mice (Fig. 2c) . Table 1 shows that no differences in hemodynamic parameters were observed.
In view of our recent work with AnxA1 null macrophages [21] , we then tested the extent of zymosan phagocytosis in extravasated PMN. The results obtained indicated no difference between the two genotypes, with calculated values (percentage of extravasated PMN phagocytosing zymosan particles) of 50 Ϯ 6% and 54 Ϯ 5% (nϭ4, not significant).
Mouse cremaster microcirculation activated by PAF
Next, to determine whether the inhibitory effect of endogenous AnxA1 was limited to zymosan or could also be seen with another stimulus, the inflammatory response of the cremaster microvascular beds by PAF superfusion was compared with buffer control. As AnxA1 null mice have never been used to investigate potential changes in the microcirculation, initially, we monitored the effects of superfusion with control buffer. Superfusion of the preparations with buffer provoked, over time, minimal alterations in cell adhesion (Fig. 3a) and emigration (Fig. 3b) . Similarly, no changes in cell rolling (velocity values being in the range of 50 -80 m/s over the time course analyzed, with no difference between genotype) were detected up to 90 min. It is important that AnxA1 null mice displayed an identical response with respect to all these cellular parameters, and this apparent lack of "physiological role" for AnxA1 in these settings was also evident from the analysis of the hemodynamic parameters ( Table 2) .
In contrast to buffer superfusion, superfusion of the cremaster microcirculation of wild-type mice with PAF provoked a significant, time-dependent increase in cell adhesion and em- Wild-type and Anx-A1 null mice were injected with saline or zymosan (30 g in 400 l saline) at time 0. Mice were prepared for intravital microscopy at the 6-h time-point. Vessel diameter and RBC velocity were measured, and WSR was calculated, as described in Materials and Methods. Values are mean Ϯ SEM of four mice per group. igration (Fig. 3, c and d) , with no major changes in WBC velocity (not shown). Absence of AnxA1 produced a selective effect on cell emigration, but not cell adhesion, with significant augmentation (ϳ40% on net values) at 60 and 75 min superfusion. Analysis of the hemodynamic parameters did not show significant differences between the genotypes (not shown), and values were essentially in line with those reported in Table 2 .
Effect of AnxA1 gene deletion on PMN functional responses
These in vivo analyses were then complemented with a series of in vitro experiments to determine if the AnxA1 null PMN exhibited a different degree of activation in response to stimulation. Figure 4 summarizes the data obtained when CD11b expression was monitored by flow cytometry. Addition of PAF to peripheral blood aliquots for 15 min led to a concentrationdependent increase in CD11b expression on the PMN, which was evident from 0.3 M onward (Fig. 4a) . It is interesting that CD11b up-regulation was higher in AnxA1 null cells, and significance was observed at 1 M concentration, and maximal activation was measured at the highest concentration tested of 3 M PAF. This pattern of PMN activation was also observed when two other stimuli were used. AnxA1 null PMN responded maximally to 3 M fMLP, whereas a 10-M concentration was required to produce a maximal response in wild-type PMN (Fig. 4b) . The higher susceptibility of AnxA1 null PMN to fMLP was also evident at the lowest concentration tested of 1 M. Finally, in absolute terms, PMA (10 M) produced the most marked cellular response (Fig. 4c) , with significant increases in AnxA1 null cells at 3 and 10 M concentrations.
This first series of in vitro experiments indicates more susceptible PMN activation in the absence of AnxA1; and PMA efficacy in AnxA1 null cells indicates the lack of correlation for these results with potential changes in the expression of receptors for leukocyte activators.
Chemotaxis of AnxA1 null PMN
Finally, to link in vitro with in vivo analyses, PMN chemotaxis in a modified Boyden chamber assay was evaluated. Purified blood PMN responded with directed locomotion to PAF or fMLP, when applied at a concentration as low as 0.1 or 1 nM The cremaster muscle of AnxA1 null and wild-type mice was prepared for intravital microscopy and superfused with BBS (vehicle control). See Table 1 for details on parameters calculation. Values are mean Ϯ SEM of six mice per group. (Fig. 5) 
Whereas no major changes were observed in the absence of chemotactic stimulus, PMN deficient in AnxA1 displayed an augmented response to 1 nM PAF (Fig. 5a) . Again, the defect associated with absence of AnxA1 was not restricted to a single stimulus, and fMLP-stimulated cells also migrated more than purified PMN from wild-type mice (Fig. 5b) .
DISCUSSION
In the present study, we provide evidence for a tonic inhibitory role exerted by endogenous AnxA1 on PMN activation. Direct observation of the cremaster microcirculation indicates an altered extent of leukocyte emigration in the absence of AnxA1. Comparative analyses of leukocyte behavior demonstrate a higher susceptibility to activation of AnxA1 null PMN, which is likely to lead to the significant alterations in the cell behavior observed in the inflamed microcirculation.
The inhibitory role of AnxA1 on the process of leukocyte trafficking has predominantly been studied using a pharmacological approach. For instance, systemic treatment with AnxA1 or its bioactive peptides dampens PMN recruitment in several vascular beds and in response to several distinct stimuli [15] [16] [17] 28] , with the lung being an exception [29] . Less clear from such studies, though, is the role that the endogenous mediator might be playing in regulating the cellular inflammatory response. Passive immunization protocols have revealed a major role for AnxA1 in promoting the resolution phase of inflammation, such that prolonged PMN recruitment and edema formation could be measured in animals receiving neutralizing antisera [30] . The same holds true for acute joint inflammation [16] .
The recent availability of the AnxA1 null mouse provides the optimal tool to address this aspect in a more detailed manner. Initial analyses in these mice indicated specific timerelated alterations in sensitivity to inflammatory stimuli. For instance, in the mouse paw edema model, absence of AnxA1 did not modify the early phase of the response (2-4 h), whereas an augmented response was measured at later time-points (e.g., Ͼ20% at 24 h) [18] . In a second study using the antigeninduced arthritis model, a higher degree of joint inflammation was determined in the AnxA1 null mouse [19] . In the present study, we started our analysis from the zymosan peritonitis model, revealing a higher degree of PMN recruitment in AnxA1-deficient mice. This was determined by light microscopy and flow cytometry, monitoring Gr1 ϩ cells. Associated with higher Gr1 ϩ cells, a lower content of F4/80 ϩ cells in the AnxA1 mice was measured at the 4-h time-point. In this model of peritonitis, rapid disappearance of macrophages occurs as early as 1-2 h [31] , with a partial reappearance at 4 h postzymosan injection. This "macrophage disappearance response" is possibly linked to higher cell adhesion to serosal mucosae as well as to rapid mobilization to mesenteric lymph nodes [32, 33] and is indicative of a prolonged activation status. These in vivo results complement previous data describing an early defect in phagocytosis and altered profiles of activation of AnxA1 null macrophages [21] .
To determine whether the augmented PMN trafficking in response to zymosan was associated to a tonic effect of endogenous AnxA1 on the early events of the leukocyte-endothelium interaction process, we turned to intravital microscopy, monitoring the zymosan response in the cremaster microcirculation [26] . Intrascrotal injection of zymosan provoked a marked degree of activation within the microcirculation that was selectively altered by AnxA1 gene deficiency: no changes in the extent of cell rolling and adhesion could be measured, whereas there was a much higher number of emigrated leukocytes. It is conceivable that this augmented response in AnxA1-deficient mice could be related to multiple effects including abnormal activation of resident cells (e.g., macrophage, discussed above) and of the mechanisms that lead to PMN trafficking; in any case, the selectivity of effect of endogenous AnxA1 on the leukocyte emigration step of the trafficking cascade was unequivocal. Noteworthy, pharmacological studies with AnxA1 and its peptido-mimetics pointed to alteration of postadhesion phenomena as the site of action for the antimigratory properties of these compounds [15, 17] . This aspect was further investigated using a direct PMN stimulant. Superfusion of PAF onto the cremaster produced the expected cascade of leukocyte rolling, adhesion, and emigration events [34, 35] , congruent with the accepted model of cell recruitment [36, 37] . Again, endogenous AnxA1 exerted a tonic inhibitory control selectively on WBC emigration across the endothelial wall, demonstrating that its counter-regulatory effect was not restricted to a specific stimulus. In line with these new findings with the AnxA1 null mouse, PAF-induced activation of the hamster cheek-pouch microcirculation revealed a role for endogenous AnxA1 in mediating the antimigratory effect of dexamethasone, with alteration of the fate of the adherent leukocytes, provoking detachment and preventing cell emigration [38] .
Another interesting point to highlight is the lack of alterations in the AnxA1 null mouse when the cremaster microcirculation was superfused with buffer (up to 90 min). Thus, the AnxA1 counter-regulatory effect is unlikely to have a function in resting conditions, but rather, it becomes operative in pathological settings, such as after zymosan-or PAF-induced activation of the leukocyte trafficking in the microcirculation.
Prompted by the results obtained with PAF and intravital microscopy, the final part of the study focused on the analysis of PMN functions using two in vitro assays of cell activation. The results obtained indicate that AnxA1 deficiency is associated with exaggerated PMN activation. However, this occurs in a discrete and stimulus-independent manner. Using a whole blood assay to minimize cell activation as a result of purification procedures, it was found that AnxA1 null PMN responded more swiftly to fMLP, PAF, or PMA, as measured by upregulation of CD11b on the plasma membrane. It is of interest, in this context, to recollect that a series of biochemical studies have highlighted a role for this protein and its N-terminal domain in mediating fusion of PMN granules with membrane preparations [7, 39] . It is therefore possible that the PMN cytoplasmic pool of endogenous AnxA1 [10] might localize at the fusion areas between specific granules and plasma membrane. It is relevant that activation of specific granules with consequent increased cell-surface CD11b expression has been postulated to "serve" the PMN machinery during subendothelial cell chemotaxis [40, 41] . The specific intracellular process(es) tonically inhibited by AnxA1 are currently unclear, although initial determinations of F-actin formation suggest that the site of action for this anti-inflammatory protein is down-stream of this pivotal process (S. Yona, unpublished data).
Along the same lines are the data obtained in the experiments of PMN chemotaxis, in which two distinct activators were applied. Again, a subtle defect was observed in the absence of AnxA1, with an augmented degree of cell chemotaxis at low-intermediate concentrations of stimulants. This set of data matches well with the in vivo observations made in the mouse cremaster microcirculation and discussed above and confirms that endogenous AnxA1 plays an important inhibitory role in PMN locomotion.
In conclusion, analysis of PMN activation assays in vitro showed alterations in selected processes (i.e., CD11b up-regulation and PMN chemotaxis), likely to impact on those operating in the inflamed microcirculation. The results obtained with this first study support the hypothesis that endogenous AnxA1 plays an important regulatory role for this endogenous mediator on PMN activation in vitro and recruitment in vivo.
